Avid Bioservices Inc (CDMO)
8.425
+0.18
(+2.12%)
USD |
NASDAQ |
May 06, 16:00
8.425
0.00 (0.00%)
After-Hours: 18:09
Avid Bioservices Free Cash Flow: -38.50M for Jan. 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| January 31, 2024 | -38.50M |
| October 31, 2023 | -55.94M |
| July 31, 2023 | -92.96M |
| April 30, 2023 | -90.52M |
| January 31, 2023 | -92.40M |
| October 31, 2022 | -88.99M |
| July 31, 2022 | -47.76M |
| April 30, 2022 | -46.95M |
| January 31, 2022 | -9.279M |
| October 31, 2021 | 8.002M |
| July 31, 2021 | 12.94M |
| April 30, 2021 | 21.32M |
| January 31, 2021 | 9.865M |
| October 31, 2020 | 4.737M |
| July 31, 2020 | 1.759M |
| April 30, 2020 | 2.015M |
| January 31, 2020 | 5.149M |
| October 31, 2019 | 3.941M |
| July 31, 2019 | -7.963M |
| April 30, 2019 | -13.10M |
| January 31, 2019 | -18.03M |
| October 31, 2018 | -23.12M |
| July 31, 2018 | -24.81M |
| April 30, 2018 | -29.78M |
| January 31, 2018 | -42.78M |
| Date | Value |
|---|---|
| October 31, 2017 | -46.22M |
| July 31, 2017 | -37.21M |
| April 30, 2017 | -42.80M |
| January 31, 2017 | -36.85M |
| October 31, 2016 | -35.21M |
| July 31, 2016 | -48.34M |
| April 30, 2016 | -48.47M |
| January 31, 2016 | -48.53M |
| October 31, 2015 | -49.45M |
| July 31, 2015 | -49.40M |
| April 30, 2015 | -45.07M |
| January 31, 2015 | -45.14M |
| October 31, 2014 | -42.07M |
| July 31, 2014 | -34.85M |
| April 30, 2014 | -29.01M |
| January 31, 2014 | -27.17M |
| October 31, 2013 | -25.48M |
| July 31, 2013 | -29.64M |
| April 30, 2013 | -21.78M |
| January 31, 2013 | -26.08M |
| October 31, 2012 | -28.06M |
| July 31, 2012 | -28.09M |
| April 30, 2012 | -37.43M |
| January 31, 2012 | -35.49M |
| October 31, 2011 | -33.40M |
Free Cash Flow Range, Past 5 Years
-92.96M
Minimum
Jul 2023
21.32M
Maximum
Apr 2021
-26.40M
Average
-7.963M
Median
Jul 2019
Free Cash Flow Benchmarks
| Emergent BioSolutions Inc | -257.90M |
| Creative Medical Technology Holdings Inc | -8.128M |
| Viking Therapeutics Inc | -54.87M |
| Stereotaxis Inc | -9.505M |
| MAIA Biotechnology Inc | -13.07M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.687M |
| Cash from Investing (Quarterly) | -4.488M |
| Cash from Financing (Quarterly) | 0.085M |
| Free Cash Flow Per Share (Quarterly) | -0.0127 |
| Free Cash Flow to Equity (Quarterly) | -1.068M |
| Free Cash Flow to Firm (Quarterly) | -0.0564M |
| Free Cash Flow Yield | -7.21% |